Abstract
The possible role of gammaaminobutyric acid (GABA) in the pathophysiology of restless legs syndrome (RLS) is suggested by the symptomatic improvement achieved with GABAergic drugs. Thalamic GABA levels have shown positive correlation with periodic limb movements indices and with RLS severity. We tried to investigate the possible association between the most common single nucleotide polymorphisms (SNPs) in the GABA receptors (GABR) genes rho1, 2, and 3 (GABRR1, GABRR2, GABRR3), alpha4 (GABRA4), epsilon (GABRE), and theta (GABRQ) with the risk of developing RLS. We studied the genotype and allelic variant frequencies of the most common SNPs in the GABRR1(rs12200969, rs1186902), GABRR2(rs282129), GABRR3(rs832032), GABRA4(rs2229940), GABRE(rs1139916), and GABRQ(rs3810651) genes in 205 RLS patients and 230 age- and gender-matched healthy controls using specific TaqMan assays. The frequencies of the GABRR3 rs832032TT genotype and the allelic variant GABRR3 rs832032T were significantly higher in RLS patients than in controls (odds ratio [95% confidence intervals] 7.08[1.48–46.44] and 1.66[1.16–2.37], respectively), although only the higher frequency of the rs832032T allele remained as significant after multiple comparison analysis, both in the whole series and in the female gender. The frequencies of the other genotypes of allelic variants did not differ significantly between RLS patients and controls. RLS patients carrying the GABRA4 rs2229940TT genotype showed a significantly younger age at onset of RLS symptoms than those with the other two genotypes. These results suggest association between GABRR3rs832032 polymorphism and the risk for RLS, and a modifier effect of GABRA4 rs2229940 on the age of onset of RLS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Genetics of restless legs syndrome: an update. Sleep Med Rev. 2018;39:108–21.
Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 2017;16:898–907.
García-Martín E, Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, et al. Heme oxygenase-1 and 2 common genetic variants and risk for restless Legs Syndrome. Medicine 2015;94:e1448.
Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, et al. Association between vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless Legs Syndrome in the Spanish Caucasian Population. Medicine. 2015;94:e2125.
Jiménez-Jiménez FJ, Gómez-Tabales J, Alonso-Navarro H, Zurdo M, Turpín-Fenoll L, Millán-Pascual J, et al. Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless Legs Syndrome. Sleep. 2017;40. https://doi.org/10.1093/sleep/zsx174.
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Neurochemistry of idiopathic restless legs syndrome. Eur Neurol Rev. 2015;10:35–44. http://www.touchneurology.com/articles/neurochemistry-idiopathic-restless-legs-syndrome
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Treatment options for idiopathic restless legs syndrome. Eur Neurol Rev. 2015;10:45–55. http://www.touchneurology.com/articles/treatment-options-idiopathic-restless-legs-syndrome
Winkelman JW, Schoerning L, Platt S, Jensen JE. Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity. Sleep Med. 2014;15:1225–30.
IUPHAR DATABASE. Nomenclature of ligand-gates ion channels. Available at http://www.iuphar-db.org/LGIICNomenclature.jsp.
Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharmacol Rev. 2008;60:243–60.
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless Legs Syndrome diagnosis and epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the National Institute of Health. Sleep Med. 2003;4:101–19.
Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW. et al.International Restless Legs Syndrome Study Group 2014 Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria - history, rationale, description, and significance. Sleep Med. 2014;15:860–73.
Roco A, Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, et al. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome. J Neural Transm. 2013;120:463–7.
Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán J, et al. Dopamine Receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome. Sleep Med. 2013;14:382–4.
Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán J, et al. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome. Sleep Med. 2014;15:266–8.
Jiménez-Jiménez FJ, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, Millán J, et al. Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome. J Neural Transm. 2015;122:819–23.
Jiménez-Jiménez FJ, García-Martín E, Alonso-Navarro H, Martínez C, Zurdo M, Turpín-Fenoll L, et al. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl- transferase (HNMT) gene and risk for restless legs syndrome. J Neural Transm. 2017;124:285–291.
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B. 1995;1:289–300.
Daly AK, Day CP. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol. 2001;52:489–99.
Pértegas Díaz S, Pita Fernández S. Cálculo del poder estadístico de un estudio. Cad Aten Prima. 2003;10:59–63.
Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ. 1994;309:102.
Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E. Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol. 2010;10:71.
García Martín E, Ramos MI, Cornejo-García JA, Galván S, Perkins JR, Rodríguez-Santos L, et al. Missense gamma-aminobutyric acid receptor polymorphisms are associated with reaction time, motor time, and ethanol effects in vivo. Front Cell Neurosci. 2018;12:10. https://doi.org/10.3389/fncel.2018.00010
Bustamante MF, Morcillo-Suárez C, Malhotra S, Rio J, Leyva L, Fernández O, et al. Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β. Neurol Neuroimmunol Neuroinflamm. 2015;2:e154.
Agrawal A, Pergadia ML, Saccone SF, Hinrichs AL, Lessov-Schlaggar CN, Saccone NL, et al. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction. 2008;103:1027–38.
García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. J Neurol. 2011;258:203–11.
García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharm Genom. 2011;21:436–9.
García Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Esguevillas G, et al. Gamma-aminobutyric acid (GABA) receptors rho (GABRR) gene polymorphisms and risk for migraine. Headache. 2016;57:1118–35.
Acknowledgements
This work was supported in part by Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain (Grants PI15/00303 and RETICS ARADyAL RD16/0006/0004), Junta de Extremadura, Mérida, Spain (Grants GR15026 and IB16170), Fundesalud, Mérida, Spain (Grant PRIS10016), and Spanish Ministry of Science and Innovation (Grants SAF2006-10126 and SAF2010-22329-C02-01). Partially funded with FEDER funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jiménez-Jiménez, F.J., Esguevillas, G., Alonso-Navarro, H. et al. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome. Pharmacogenomics J 18, 565–577 (2018). https://doi.org/10.1038/s41397-018-0023-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41397-018-0023-7
This article is cited by
-
A pioneering study indicate role of GABRQ rs3810651 in ASD severity of Indo-Caucasoid female probands
Scientific Reports (2021)
-
Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome
Journal of Neurology (2021)
-
IL1B polymorphism is associated with essential tremor in Chinese population
BMC Neurology (2019)